Replies to post #93736 on Biotech Values

[biomaven0]

restructuring of the partnership that results in additional cash for ariad

I'd be very surprised if that were the case. All I am expecting is something that caps Aria's spend at reasonable levels. If I am correct, and we also accept management's assurances of no new raise, then a 534 partnership with a hefty upfront is likely also near.

Peter